AlphaGen (Drug Discovery) Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 2

AlphaGen (Drug Discovery) General Information

Description

Developer of radiopharmaceutical products designed for targeted oncology treatments. The company utilizes a radionuclide technology platform and lead-212 isotope extraction to produce alpha and beta radioligand therapies, enabling healthcare providers to deliver targeted radiation to tumor cells while minimizing damage to healthy tissues.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 619, Building 1, Kangda Yuangu
  • Number 2966 Jinke Road
  • Shanghai, 201203
  • China
+86 021
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
  • Room 619, Building 1, Kangda Yuangu
  • Number 2966 Jinke Road
  • Shanghai, 201203
  • China
+86 021

AlphaGen (Drug Discovery) Timeline

2023202420252026
Date FoundedFinancing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AlphaGen (Drug Discovery) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 18-Oct-2025 Completed Generating Revenue
2. Early Stage VC (Series A) 07-Aug-2025 Completed Generating Revenue
1. Early Stage VC 18-Oct-2023 $29.6M $29.6M Completed Generating Revenue
To view AlphaGen (Drug Discovery)’s complete valuation and funding history, request access »

AlphaGen (Drug Discovery) Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Eight Roads Corporate Venture Capital Minority
F-Prime Venture Capital Minority
To view AlphaGen (Drug Discovery)’s complete investors history, request access »

AlphaGen (Drug Discovery) FAQs

  • When was AlphaGen (Drug Discovery) founded?

    AlphaGen (Drug Discovery) was founded in 2022.

  • Where is AlphaGen (Drug Discovery) headquartered?

    AlphaGen (Drug Discovery) is headquartered in Shanghai, China.

  • What industry is AlphaGen (Drug Discovery) in?

    AlphaGen (Drug Discovery)’s primary industry is Drug Discovery.

  • Is AlphaGen (Drug Discovery) a private or public company?

    AlphaGen (Drug Discovery) is a Private company.

  • What is AlphaGen (Drug Discovery)’s current revenue?

    The current revenue for AlphaGen (Drug Discovery) is .

  • How much funding has AlphaGen (Drug Discovery) raised over time?

    AlphaGen (Drug Discovery) has raised $47.1M.

  • Who are AlphaGen (Drug Discovery)’s investors?

    Eight Roads and F-Prime have invested in AlphaGen (Drug Discovery).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process